Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Chronic kidney disease in patients over 80 years after myocardial infarction: The role of biomarkers and albuminuria in predicting outcomes (a prospective 12-month study).].

Created on 26 Jul 2026

Authors

I A Zolotvskaya, M E Ramodina, M A Pashina, P R Shatskay

Published in

Advances in gerontology = Uspekhi gerontologii. Volume 39. Issue 3. Pages 371-376.

Abstract

The analysis of the progression of chronic kidney disease (CKD) and cardiovascular events was performed in 318 patients aged 80 years and older during 12 months after myocardial infarction (MI). Patients were divided into 2 groups: with CKD (n=164) and without CKD (n=154). It was found that in patients with CKD, the urinary concentration of KIM-1 and the level of microalbuminuria (UACR) were significantly higher and remained elevated during the year, correlating with the rate of eGFR decline (r=-0,47; p<0,01) and NT-proBNP level. The median time to cardiovascular event in the CKD group was 198 [112; 289] days versus 312 [245; 358] days in the comparison group (p<0,001). The risk of the composite endpoint (death, recurrent MI, stroke) in the CKD group was 2,9 times higher (p<0,001). Independent predictors of adverse outcomes were KIM-1 >1,5 ng/ml (HR=2,3), UACR >30 mg/g (HR=2,1) and anemia (HR=1,8). The obtained data confirm that KIM-1 and microalbuminuria are significant predictors of adverse renal and cardiac prognosis in geriatric patients.

PMID:
42502930
Bibliographic data and abstract were imported from PubMed on 26 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 26
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement